Inherited susceptibility to chronic lymphocytic leukemia: Evidence and prospects for the future

Therapeutic Advances in Hematology

Volumn 4, Issue 4, 2013, Pages 298-308

  Brown, Jennifer R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

CLL; copy number variant; familial; genomewide association study; linkage; monoclonal B lymphocytosis

Indexed keywords

EID: 84993768044     PISSN: 20406207     EISSN: 20406215     Source Type: Journal    
DOI: 10.1177/2040620713495639     Document Type: Article

References (79)

1. Ahmadiyeh N. Pomerantz M.M. Grisanzio C. Herman P. Jia L. Almendro V. et al. (2010) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proceedings of the National Academy of Sciences of the United States of America 107: 9742–9746
2. Broderick P. Sellick G. Fielding S. Catovsky D. Houlston R. (2008) Lack of a relationship between the common 18q24 variant rs 12953717 and risk of chronic lymphocytic leukemia. Leukemia Lymphoma 49: 271–272.
3. Brown J. (2008) Inherited predisposition to chronic lymphocytic leukemia. Expert Rev Hematol 1: 51–61.
4. Brown J. Hanna M. Tesar B. Pochet N. Vartanov A. Fernandes S. et al. (2012 a) Germline copy number variation associated with Mendelian inheritance of CLL in two families. Leukemia 26: 1710–1713.
5. Brown J. Hanna M. Tesar B. Werner L. Pochet N. Asara J. et al. (2012 b) Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res 18: 3791–3802.
6. Brown J. Neuberg D. Phillips K. Reynolds H. Silverstein J. Clark J. et al. (2008 a) Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders. Br J Haematol 143: 361–368.
7. Brown J. Rassenti L. Neuberg D. Greaves A. Byrd J. Grever M. et al. (2008 b) Characteristics of Familial CLL Evaluated in the CLL Research Consortium Cohort. Blood 112: abstract 3125.
8. Calin G.A. Ferracin M. Cimmino A. Di Leva G. Shimizu M. Wojcik S.E. et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England Journal of Medicine 353: 1793–1801.
9. Capalbo S. Trerotoli P. Ciancio A. Battista C. Serio G. Liso V. (2000) Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage. Eur J Haematol 65: 114–117.
10. Caporaso N. Marti G. Goldin L. (2004) Perspectives on familial chronic lymphocytic leukemia: genes and the environment. Semin Hematol 41: 201–206.
11. Chang E. Smedby K. Hjalgrim H. Porwit-MacDonald A. Roos G. Glimelius B. et al. (2005) Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst 97: 1466–1474.
12. Cimmino A. Calin G. Fabbri M. Iorio M. Ferracin M. Shimizu M. et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102: 13944–13949.
13. Coombs C. Rassenti L. Falchi L. Slager S. Strom S. Ferrajoli A. et al. (2012) Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans. Blood 120: 1687–1690.
14. Crowther-Swanepoel D. Broderick P. Di Bernardo M. Dobbins S. Torres M. Mansouri M. et al. (2010 a) Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet 42: 132–136.
15. Crowther-Swanepoel D. Broderick P. Ma Y. Robertson L. Pittman A. Price A. et al. (2010 b) Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus. Hum Mol Genet 19: 1840–1845.
16. Crowther-Swanepoel D. Corre T. Lloyd A. Gaidano G. Olver B. Bennett F. et al. (2010 c) Inherited genetic susceptibility to monoclonal B-cell lymphocytosis. Blood 116: 5957–5960.
17. Crowther-Swanepoel D. Qureschi M. Dyer M.J. Matutes E. Dearden C. Catovsky D. et al. (2009) Genetic variation in CXCR 4 and risk of chronic lymphocytic leukemia. Blood 114: 4843–4846.
18. Crowther D. Wild R. Sellick G. Dyer M. Mauro F. Cuthbert R. et al. (2008) Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL. Blood 111: 5691–5693.
19. Dagklis A. Fazi C. Sala C. Cantarelli V. Scielzo C. Massacane R. et al. (2009) The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood 114: 26–32.
20. Davids M. Burger J. (2012) Cell trafficking in chronic lymphocytic leukemia. Open J Hematol 3(Suppl. 1): PMID 22844583.
21. de Tute R. Yuille M. Catovsky D. Houlston R. Hillmen P. Rawstron A. (2006) Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults. Leukemia 20: 728–729.
22. Deng H. (2001) Population admixture may appear to mask, change or reverse genetic effects of genes underlying complex traits. Genetics 159: 1319–1323.
23. Deng H. Chen W. Recker R. (2001) Population admixture: detection by Hardy–Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics 157: 885–897.
24. Di Bernardo M.C. Broderick P. Harris S. Dyer M.J. Matutes E. Dearden C. et al. (2013) Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation. Leukemia 27: 255–258.
25. Di Bernardo M. Crowther-Swanepoel D. Broderick P. Webb E. Sellick G. Wild R. et al. (2008) A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 40: 1204–1210.
26. Dworkin A.M. Ridd K. Bautista D. Allain D.C. Iwenofu O.H. Roy R. et al. (2010) Germline variation controls the architecture of somatic alterations in tumors. PLoS Genet 6 (9).
27. Ghia P. Prato G. Scielzo C. Stella S. Geuna M. Guida G. et al. (2004) Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 103: 2337–2342.
28. Goldin L. Caporaso N. (2007) Family studies in chronic lymphocytic leukemia and other lymphoproliferative tumors. Br J Hematol 139: 774–779.
29. Goldin L. Lanasa M. Slager S. Cerhan J. Vachon C. Strom S. et al. (2010 a) Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol 151: 152–158.
30. Goldin L. Landgren O. Marti G. Caporaso N. (2010 b) Familial aspects of chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis (MBL), and related lymphomas. Eur J Clin Med Oncol 2: 119–126.
31. Goldin L. Pfeiffer R. Li X. Hemminki K. (2004) Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 104: 1850–1854.
32. Havelange V. Pekarsky Y. Nakamura T. Palamarchuk A. Alder H. Rassenti L. et al. (2011) IRF 4 mutations in chronic lymphocytic leukemia. Blood 118: 2827–2829.
33. Jonsson V. Houlston R. Catovsky D. Yuille M. Hilden J. Olsen J. et al. (2005) CLL family ‘Pedigree 14’ revisited: 1947–2004. Leukemia 19: 1025–1028.
34. Klein U. Casola S. Cattoretti G. Shen Q. Lia M. Mo T. et al. (2006) Transcription factor IRF 4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7: 773–782.
35. Krepischi A.C. Pearson P.L. Rosenberg C. (2012) Germline copy number variations and cancer predisposition. Future Oncol 8: 441–450.
36. Lanasa M. Allgood S. Slager S. Dave S. Love C. Marti G. et al. (2011) Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia 25: 1459–1466.
37. Landgren O. Albitar M. Ma W. Abbasi F. Hayes R. Ghia P. et al. (2009) B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 360: 659–667.
38. Lia M. Carette A. Tang H. Shen Q. Mo T. Bhagat G. et al. (2012) Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood 119: 2981–2990.
39. Li Q. Seo J. Stranger B. McKenna A. Pe'er I. Laframboise T. et al. (2013) Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152: 633–641.
40. Lupski J. Belmont J. Boerwinkle E. Gibbs R. (2011) Clan genomics and the complex architecture of human disease. Cell 147: 32–43.
41. Marti G. Carter P. Abbasi F. Washington G. Jain N. Zenger V. et al. (2003) B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom 52: 1–12.
42. Marti G. Rawstron A. Ghia P. Hillmen P. Houlston R. Kay N. et al. (2005) Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 130: 325–332.
43. Matos D.M. Ismael S.J. Scrideli C.A. de Oliveira F.M. Rego E.M. Falcao R.P. (2009) Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia. Br J Haematol 147: 339–346.
44. Mauro F. Giammartini E. Gentile M. Sperduti I. Valle V. Pizzuti A. et al. (2006) Clinical features and outcome of familial chronic lymphocytic leukemia. Haematologica 91: 1117–1120.
45. Mittrucker H. Matsuyama T. Grossman A. Kundig T. Potter J. Shahinian A. et al. (1997) Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275: 540–543.
46. Ng D. Toure O. Wei M. Arthur D. Abbasi F. Fontaine L. et al. (2007) Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia. Blood 109: 916–925.
47. Nieto W. Almeida J. Romero A. Teodosio C. Lopez A. Henriques A. et al. (2009) Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 114: 33–37.
48. Pang J. Cook L. Schwartz S. Weiss N. (2002) Incidence of leukemia in Asian migrants to the United States and their descendants. Cancer Causes Control 13: 791–795.
49. Pottern L. Linet M. Blair A. Dick F. Burmeister L. Gibson R. et al. (1991) Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res 15: 305–314.
50. Pritsch O. Troussard X. Magnac C. Mauro F. Davi F. Payelle-Brogard B. et al. (1999) VH gene usage by family members affected with chronic lymphocytic leukaemia. Br J Haematol 107: 616–624.
51. Rassenti L. Toy T. Huynh L. Greaves A. Gribben J. Keating M. et al. (2003) High similarity between familial and sporadic cases of chronic lymphocytic leukemia. Blood 102: 670a.
52. Raval A. Tanner S. Byrd J. Angerman E. Perko J. Chen S. et al. (2007) Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129: 879–890.
53. Rawstron A. Bennett F. O'Connor S. Kwok M. Fenton J. Plummer M. et al. (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359: 575–583.
54. Rawstron A. Green M. Kuzmicki A. Kennedy B. Fenton J. Evans P. et al. (2002 a) Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 100: 635–639.
55. Rawstron A. Shanafelt T. Lanasa M. Landgren O. Hanson C. Orfao A. et al. (2010) Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 78(Suppl. 1): S19–S23.
56. Rawstron A. Yuille M. Fuller J. Cullen M. Kennedy B. Richards S. et al. (2002 b) Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 100: 2289–2290.
57. Rossi D. Sozzi E. Puma A. de Paoli L. Rasi S. Spina V. et al. (2009) The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 146: 64–75.
58. Ruchlemer R. Polliack A. (2013) Geography, ethnicity and “roots” in chronic lymphocytic leukemia. Leuk Lymphoma 54: 1142–1150.
59. Rudd M. Sellick G. Webb E. Catovsky D. Houlston R. (2006) Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 108: 638–644.
60. Sakai A. Marti G. Caporaso N. Pittaluga S. Touchman J. Fend F. et al. (2000) Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL. Blood 95: 1413–1419.
61. Sellick G. Catovsky D. Houlston R. (2006) Familial chronic lymphocytic leukemia. Semin Oncol 33: 195–201.
62. Sellick G. Goldin L. Wild R. Slager S. Ressenti L. Strom S. et al. (2007) A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia. Blood 110: 3326–3333.
63. Sellick G. Webb E. Allinson R. Matutes E. Dyer M. Jonsson V. et al. (2005) A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. Am J Hum Genet 77: 420–429.
64. Setlur S. Ihm C. Tchinda J. Shams S. Werner L. Cho E. et al. (2010) Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization. Br J Haematol 151: 336–345.
65. Shanafelt T. Kay N. Rabe K. Call T. Zent C. Maddocks K. et al. (2009) Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 27: 3959–3963.
66. Shlien A. Malkin D. (2009) Copy number variations and cancer. Genome Med 1: 62.
67. Sille F. Thomas R. Smith M. Conde L. Skibola C. (2012) Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia. PloS ONE 7 (1): e29632.
68. Slager S. Achenbach S. Asmann Y. Camp N. Rabe K. Goldin L. et al. (2013) Mapping of the IRF 8 gene identifies a 3’UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 22: 461–466.
69. Slager S. Rabe K. Achenbach S. Vachon C. Goldin L. Strom S. et al. (2011) Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 117: 1911–1916.
70. Slager S.L. Skibola C.F. Di Bernardo M.C. Conde L. Broderick P. McDonnell S.K. et al. (2012) Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood 120: 843–846.
71. Tesar B. Werner L. Hanna M. Improgo M. Pochet N. Fernandes S. et al. (2012) Risk alleles identified in genome-wide association studies are associated with expression quantitative trait loci in chronic lymphocytic leukemia. Blood 120: 2875.
72. Theodorou I. Abel L. Mauro F. Duprey B. Magnac C. Payelle-Brogard B. et al. (2002) High occurence of DRB 1 11 in chronic lymphocytic leukaemia families. Br J Haematol 119: 713–715.
73. Tjonnfjord G. Jonsson V. Ly B. Johannesen T. (2012) Familial occurrence of chronic lymphocytic leukaemia in Norway. Tidsskr Nor Laegeforen 132: 2060–2063.
74. Vogt R. Shim Y. Middleton D. Buffler P. Campolucci S. Lybarger J. et al. (2007) Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies. Br J Haematol 139: 690–700.
75. Wang K. Diskin S.J. Zhang H. Attiyeh E.F. Winter C. Hou C. et al. (2011) Integrative genomics identifies LMO 1 as a neuroblastoma oncogene. Nature 469: 216–220.
76. Wright J.B. Brown S.J. Cole M.D. (2010) Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol 30: 1411–1420.
77. Yochum G.S. Sherrick C.M. Macpartlin M. Goodman R.H. (2010) A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5’ and 3’ Wnt responsive enhancers. In: Proceedings of the National Academy of Sciences of the United States of America 107: 145–150.
78. Yuille M. Houlston R. Catovsky D. (1998) Anticipation in familial chronic lymphocytic leukaemia. Leukemia 12: 1696–1698.
79. Zhang W. Kater A. Widhopf G. II Chuang H. Enzler T. James D. et al. (2010) B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 107: 18956–18960.